Table 2: Immunohistochemical endometrial polyps features: Group A (treatment) versus Group B (controls).

GroupTotal numberStromal ERs intensityNumber (%) Glandular ERs intensityNumber (%)

A12Low2 (16.7)Low2 (16.7)0.05
High10 (83.3)0.02High10 (83.3)
B10Low9 (90)Low4 (40)
High1 (10)High6 (60)

GroupTotal numberPercentage of stromal ERs Number (%) Percentage of glandular ERs Number (%)

A125–30%1 (8.3)5–30%0n.s.
30–60%9 (75)30–60%4 (33.3)
>60%2 (16.7)n.s.>60%8 (66.7)
B105–30%5 (50)5–30%0
30–60%5 (50)30–60%7 (70)
>60%0 (0)>60%3 (30)

GroupTotal numberStromal PRs intensityNumber (%) Glandular PRs intensityNumber (%)

A12Low1 (8.3)Low0 (0)n.s.
High11 (91.7)n.s.High12 (100)
B10Low1 (10)Low(0)
High9 (90)High10 (100)

GroupTotal numberPercentage of stromal PRsNumber (%) Percentage of glandular PRsNumber (%)

A125–30%1 (8.3)5–30%0 (0)n.s.
30–60%4 (33.3)30–60%1 (8.3)
>60%7 (58.3)n.s.>60%11 (91.7)
B105–30%0 (0)5–30%0 (0)
30–60%7 (70)30–60%2 (20)
>60%3 (30)>60%8 (80)

ERs: estrogen receptors; PRs: progesterone receptors.